Gsk (GLAXF) Asset Utilization Ratio (2009 - 2026)
Gsk (GLAXF) recorded quarterly Asset Utilization Ratio of 0.53 in Q1 2026, up 0.68% quarter-over-quarter from 0.53 in Q4 2025, and down 18.17% on a YoY basis from 0.65 in Q1 2025.
Gsk (GLAXF) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Gsk's Asset Utilization Ratio history runs 18 years deep, the most recent figure standing at 0.53 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 18.17% year-over-year to 0.53; the TTM figure through Mar 2026 stood at 0.53 (down 18.17% YoY), while the FY2025 annual figure was 0.55, up 2.46% from the prior year.
- Asset Utilization Ratio was 0.53 for Q1 2026 at Gsk, up from 0.53 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q4 2024 to a low of 0.41 in Q3 2022.
- Historically, Asset Utilization Ratio has averaged 0.58 across 5 years, with a median of 0.61 in 2023.
- Biggest YoY gain for Asset Utilization Ratio was 97.61% in 2022; the steepest drop was 36.9% in 2022.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.62 in 2022, then decreased by 3.38% to 0.6 in 2023, then gained by 7.78% to 0.65 in 2024, then dropped by 19.06% to 0.53 in 2025, then rose by 0.68% to 0.53 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.53 (Q1 2026), 0.53 (Q4 2025), and 0.63 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.53 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.63 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.48 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.46 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.12 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.55 |
| 10 | Gsk | - | - | 7.76 Bn | 0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.53 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.65 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.64 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.61 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.64 |
| Jun 30, 2021 | 0.65 |